MAP1LC3A and neoplasm: Groups with low Gal-1 expression (Gal-1– LC3– and Gal-1– LC3+) had larger tumor size (p < 0.001), higher stage (p = 0.005), and higher frequencies of tumor recurrence (p = 0.033) and deaths (p < 0.001) than groups with high Gal-1 expression (Gal-1+ LC3– and Gal-1+ LC3+) (Supplementary Table 1).